Prosecution Insights
Last updated: May 29, 2026

Examiner: SPANGLER, JOSEPH RANKIN

Tech Center 1600 • Art Units: 1656

This examiner grants 38% of resolved cases

Performance Statistics

38.5%
Allow Rate
-21.5% vs TC avg
101
Total Applications
+63.3%
Interview Lift
1268
Avg Prosecution Days
Based on 52 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
10.3%
§102 Novelty
58.7%
§103 Obviousness
4.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18032105 WW-DOMAIN-ACTIVATED EXTRACELLULAR VESICLES Non-Final OA President and Fellows of Harvard College
17438088 AMYLASES AND METHODS FOR MAKING AND USING THEM Final Rejection BASF SE
18985413 Culture conditions for high production of antibiotic compound aureothin from Streptomyces thioluteus Non-Final OA KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
18288401 METHOD OF DETECTING BACTERIAL/FUNGAL CONTAMINATION Non-Final OA National University of Singapore
17434832 Precise Gene Activation Via Novel Designed Proteins Mediating Epigenetic Remodeling Final Rejection UNIVERSITY OF WASHINGTON
17609841 GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYHEXANEDIOIC ACID, (E)-HEX-2-ENEDIOIC ACID AND/OR HEXANEDIOIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICALS Non-Final OA TORAY INDUSTRIES, INC.
17624764 METHODS FOR DIAGNOSING MULTIPLE SCLEROSIS Final Rejection OXFORD UNIVERSITY INNOVATION LIMITED
17433767 PROTEIN HYDROLYSATES WITH INCREASED YIELD OF N-TERMINAL AMINO ACID Non-Final OA INTERNATIONAL N&H DENMARK APS
17904189 PRODUCTION OF GLYCOSYLATED PRODUCT IN HOST CELLS Final Rejection INBIOSE N.V.
18674727 LEUCONOSTOC HOLZAPFELII STRAIN FOR PREVENTING DEPILATION IMPROVING HAIR GROWTH OR IMPROVING SEXUAL DISFUNTION AND COMPOSITION COMPRISING THE SAME Non-Final OA COENBIO CO., LTD.
17410482 FEED INGREDIENT COMPRISING BUTYRATE AND A SELECTED FERMENTATION PRODUCT Final Rejection SUPERBREWED FOOD, INC.
17418505 BIOSYNTHETIC METHODS AND SYSTEMS FOR PRODUCING MONOSACCHARIDES Final Rejection Cemvita Factory, Inc.
17435719 ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME Non-Final OA Novozymes A/S
17634909 TEXTURING L. LACTIS WITH UNIQUE EPS GENE CLUSTERS Non-Final OA Chr. Hansen A/S
16769964 SPRAY-DRIED SIALYLLACTOSE Non-Final OA Chr. Hansen A/S
17604284 MICROBIAL COMPOSITIONS AND METHODS FOR GREATER TOLERABILITY AND PROLONGED SHELF LIFE Final Rejection Pendulum Therapeutics, Inc.
17280125 Protein Composition Production Method Non-Final OA Spiber Inc.
18252354 PREPARATION OF HIGHLY CONCENTRATED ALLERGENIC INTERMEDIATE Non-Final OA Jubilant HollisterStier LLC
17431135 ENZYMES WITH RUVC DOMAINS Final Rejection Metagenomi, Inc.
17830227 METHODS AND SYSTEMS FOR PREPARING THERAPEUTIC SOLUTIONS FOR POLYMICROBIAL INFECTIONS Final Rejection CAP Diagnostics, LLC dba Pathnostics
17828811 METHOD FOR COUPLING ANTIBODY TO SURFACE OF CELL AND METHOD FOR APPLYING CELL COUPLED WITH THE ANTIBODY Final Rejection Xiamen Nuokangde Biological Technology Co., Ltd.
17730850 PROBIOTIC COMPOSITIONS AND METHODS OF USE THEREOF Final Rejection Schism Bioworks LLC
17579559 PARTICLE SEPARATOR SYSTEM, MATERIALS, AND METHODS OF USE Non-Final OA LEVITASBIO, INC.
17627488 IMMOBILIZED ENZYME COMPOSITIONS FOR THE PRODUCTION OF HEXOSES Final Rejection BONUMOSE, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month